NASDAQ: IDYA
Ideaya Biosciences Inc Stock Ownership - Who owns Ideaya Biosciences?

Insider buying vs selling

Have Ideaya Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Yujiro S. HataPresident and CEO2025-02-1812,808$19.52
$250.01kBuy

1 of 1

IDYA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IDYA insiders and whales buy or sell their stock.

IDYA Shareholders

What type of owners hold Ideaya Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc10.09%8,842,635$215.94MInstitution
Capital Research Global Investors7.48%6,552,691$160.02MInstitution
Vanguard Group Inc5.64%4,941,945$120.68MInstitution
Federated Hermes Inc5.28%4,627,266$113.00MInstitution
Timothy M. 1. Shannon3.04%2,660,713$64.97MInsider
Canaan X LP3.04%2,660,713$64.97MInsider
Geode Capital Management LLC2.41%2,113,164$51.60MInstitution
Pictet Asset Management Holding Sa2.06%1,805,136$44.08MInstitution
Fiera Capital Corp1.75%1,532,269$37.42MInstitution
Fisher Asset Management LLC1.05%922,092$22.52MInstitution

1 of 3

IDYA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IDYA46.07%8.61%Net Buying
AGIO42.89%33.30%Net SellingNet Selling
DNLI43.91%56.09%Net SellingNet Buying
IRON30.84%69.16%Net SellingNet Selling
HRMY54.01%37.22%Net Selling

Ideaya Biosciences Stock Ownership FAQ

Who owns Ideaya Biosciences?

Ideaya Biosciences (NASDAQ: IDYA) is owned by 46.07% institutional shareholders, 8.61% Ideaya Biosciences insiders, and 45.32% retail investors. Timothy M. 1. Shannon is the largest individual Ideaya Biosciences shareholder, owning 2.66M shares representing 3.04% of the company. Timothy M. 1. Shannon's Ideaya Biosciences shares are currently valued at $64.84M.

If you're new to stock investing, here's how to buy Ideaya Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.